Management Vii L.l.c. Sofinnova

Management Vii L.l.c. Sofinnova is 10% at Trius Therapeutics Inc (TSRX). They have made 2 open-market trades across 2 companies since 2011, most recently 2014-06-04.

CIK 0001421501

Get an email the next time Management Vii L.l.c. Sofinnova files.Follow for free

Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.

0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
AMRN	12,150,388	$137.5M
HPTX	1,939,474	—
TSRX	28	—
Total		$137.5M

Shares reported on the most recent Form 4, priced at the 2014-06-06 close. 2 holdings could not be priced and are excluded from the total.

Get an email the next time Management Vii L.l.c. Sofinnova files

Free account. One email when the next filing comes in.

Follow Management Vii L.l.c. Sofinnova for free

Sell Track Record

Filings2

Only 1 decision-sell filing — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.